The DOI matches its Crossref record; 131 of the 131 references it cites were found in a registry or an index.
The Epidemiology and Pathogenesis and Treatment of Pseudomonas aeruginosa Infections: An Update
Open accessAbstract
Pseudomonas aeruginosa is a Gram-negative bacterial pathogen that is a common cause of nosocomial infections, particularly pneumonia, infection in immunocompromised hosts, and in those with structural lung disease such as cystic fibrosis. Epidemiological studies have identified increasing trends of antimicrobial resistance, including multi-drug resistant (MDR) isolates in recent years. P. aeruginosa has several virulence mechanisms that increase its ability to cause severe infections, such as secreted toxins, quorum sensing and biofilm formation. Management of P. aeruginosa infections focuses on prevention when possible, obtaining cultures, and prompt initiation of antimicrobial therapy, occasionally with combination therapy depending on the clinical scenario to ensure activity against P. aeruginosa. Newer anti-pseudomonal antibiotics are available and are increasingly being used in the management of MDR P. aeruginosa.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock
Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., Jaeschke, R., et al. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e31827e83af · Cited by 9,694
Multistate point-prevalence survey of health care-associated infections
Magill, S. S., Edwards, J. R., Bamberg, W., Beldavs, Z. G., Dumyati, G., Kainer, M. A., Lynfield, R., Maloney, M., McAllister-Hollod, L., Nadle, J., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1306801 · Cited by 3,931
Kalil, A. C., Metersky, M. L., Klompas, M., Muscedere, J., Sweeney, D. A., Palmer, L. B., Napolitano, L. M., O'Grady, N. P., Bartlett, J. G., Carratalà, J., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw353 · Cited by 3,892
Hidron, A. I., Edwards, J. R., Patel, J., Horan, T. C., Sievert, D. M., Pollock, D. A., Fridkin, S. K., & National Healthcare Safety Network Team and Participating National Healthcare Safety Network Facilities (2008) · Infection Control & Hospital Epidemiology · doi:10.1086/591861 · Cited by 3,724
Surviving Sepsis Campaign: International guidelines for management of sepsis and septic shock: 2016.
Rhodes, A., Evans, L. E., Alhazzani, W., Levy, M. M., Antonelli, M., Ferrer, R., Kumar, A., Sevransky, J. E., Sprung, C. L., Nunnally, M. E., et al. (2017) · Critical Care Medicine · doi:10.1097/ccm.0000000000002255 · Cited by 3,652
Update on Key Emerging Challenges in Cystic Fibrosis
Jennings, M. T., Riekert, K. A., & Boyle, M. P. (2014) · Medical Principles and Practice · doi:10.1159/000357646 · Cited by 3,648
Siegel, J. D., Rhinehart, E., Jackson, M., & Chiarello, L. (2007) · American Journal of Infection Control · doi:10.1016/j.ajic.2007.10.007 · Cited by 3,456
Quorum sensing signal-response systems in Gram-negative bacteria
Papenfort, K., & Bassler, B. L. (2016) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2016.89 · Cited by 2,256
The surviving sepsis campaign bundle: 2018 update
Levy, M. M., Evans, L. E., & Rhodes, A. (2018) · Intensive Care Medicine · doi:10.1007/s00134-018-5085-0 · Cited by 1,445 · cited 1×
“For patients who are ill with suspected sepsis, guidelines recommend administration of antibiotics within 1 h [87].”
BackgroundTorres, A., Niederman, M. S., Chastre, J., Ewig, S., Fernandez-Vandellos, P., Hanberger, H., Kollef, M., Li Bassi, G., Luna, C. M., Martin-Loeches, I., et al. (2017) · European Respiratory Journal · doi:10.1183/13993003.00582-2017 · Cited by 1,387 · cited 2×
“Guidelines from the European Respiratory Society (ERS) recommend obtaining more distal samples, such as via BAL in order to reduce unnecessary antibiotic exposure [77].”
BackgroundSelf-citationWeiner, L. M., Webb, A. K., Limbago, B., Dudeck, M. A., Patel, J., Kallen, A. J., Edwards, J. R., & Sievert, D. M. (2016) · Infection Control & Hospital Epidemiology · doi:10.1017/ice.2016.174 · Cited by 1,313
Management of multidrug-resistant organisms in health care settings, 2006
Siegel, J. D., Rhinehart, E., Jackson, M., & Chiarello, L. (2007) · American Journal of Infection Control · doi:10.1016/j.ajic.2007.10.006 · Cited by 1,283
Kumar, A., Ellis, P., Arabi, Y., Roberts, D., Light, B., Parrillo, J. E., Dodek, P., Wood, G., Kumar, A., Simon, D., et al. (2009) · Chest · doi:10.1378/chest.09-0087 · Cited by 1,187
Farrell, P. M., Rosenstein, B. J., White, T. B., Accurso, F. J., Castellani, C., Cutting, G. R., Durie, P. R., LeGrys, V. A., Massie, J., Parad, R. B., et al. (2008) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2008.05.005 · Cited by 1,094
Cystic Fibrosis Pulmonary Guidelines: Chronic Medications for Maintenance of Lung Health
Flume, P. A., O'Sullivan, B. P., Robinson, K. A., Goss, C. H., Mogayzel, P. J., Willey-Courand, D. B., Bujan, J., Finder, J., Lester, M., Quittell, L., et al. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200705-664oc · Cited by 1,024
Prevalence and outcomes of infection among patients in intensive care units in 2017.
Vincent, J.-L., Sakr, Y., Singer, M., Martin-Loeches, I., Machado, F. R., Marshall, J. C., Finfer, S., Pelosi, P., Brazzi, L., Aditianingsih, D., et al. (2020) · JAMA · doi:10.1001/jama.2020.2717 · Cited by 1,011
Self-citationThe type III secretion system of Pseudomonas aeruginosa: infection by injection
Hauser, A. R. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2199 · Cited by 968
Tacconelli, E., Cataldo, M. A., Dancer, S. J., De Angelis, G., Falcone, M., Frank, U., Kahlmeter, G., Pan, A., Petrosillo, N., Rodríguez-Baño, J., et al. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12427 · Cited by 864
Fagon, J.-Y., Chastre, J., Wolff, M., Gervais, C., Parer-Aubas, S., Stéphan, F., Similowski, T., Mercat, A., Diehl, J.-L., Sollet, J.-P., et al. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-132-8-200004180-00004 · Cited by 854
Harris, P. N. A., Tambyah, P. A., Lye, D. C., Mo, Y., Lee, T. H., Yilmaz, M., Alenazi, T. H., Arabi, Y., Falcone, M., Bassetti, M., et al. (2018) · JAMA · doi:10.1001/jama.2018.12163 · Cited by 774
How to manage Pseudomonas aeruginosa infections
Bassetti, M., Vena, A., Croxatto, A., Righi, E., & Guery, B. (2018) · Drugs in Context · doi:10.7573/dic.212527 · Cited by 746
Cystic Fibrosis Pulmonary Guidelines: Treatment of Pulmonary Exacerbations
Flume, P. A., Mogayzel, P. J., Robinson, K. A., Goss, C. H., Rosenblatt, R. L., Kuhn, R. J., Marshall, B. C., & and the Clinical Practice Guidelines for Pulmonary Therapies Committee (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200812-1845pp · Cited by 738
Weiner-Lastinger, L. M., Abner, S., Edwards, J. R., Kallen, A. J., Karlsson, M., Magill, S. S., Pollock, D., See, I., Soe, M. M., Walters, M. S., et al. (2020) · Infection Control & Hospital Epidemiology · doi:10.1017/ice.2019.296 · Cited by 707
Kang, C.-I., Kim, S.-H., Park, W. B., Lee, K.-D., Kim, H.-B., Kim, E.-C., Oh, M.-D., & Choe, K.-W. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.2.760-766.2005 · Cited by 692
The Surviving Sepsis Campaign Bundle: 2018 Update
Levy, M. M., Evans, L. E., & Rhodes, A. (2018) · Critical Care Medicine · doi:10.1097/ccm.0000000000003119 · Cited by 679
Treatment Options for Carbapenem-resistant Gram-negative Bacterial Infections
Doi, Y. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz830 · Cited by 652
Cystic Fibrosis Pulmonary Guidelines: Chronic Medications for Maintenance of Lung Health
Mogayzel, P. J., Naureckas, E. T., Robinson, K. A., Mueller, G., Hadjiliadis, D., Hoag, J. B., Lubsch, L., Hazle, L., Sabadosa, K., Marshall, B., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201207-1160oe · Cited by 615
Assembly, structure, function and regulation of type III secretion systems
Deng, W., Marshall, N. C., Rowland, J. L., McCoy, J. M., Worrall, L. J., Santos, A. S., Strynadka, N. C. J., & Finlay, B. B. (2017) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2017.20 · Cited by 610
European cystic fibrosis society standards of care: best practice guidelines
Smyth, A. R., Bell, S. C., Bojcin, S., Bryon, M., Duff, A., Flume, P., Kashirskaya, N., Munck, A., Ratjen, F., Schwarzenberg, S. J., et al. (2014) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2014.03.010 · Cited by 582
Catheter associated urinary tract infections
Nicolle, L. E. (2014) · Antimicrobial Resistance and Infection Control · doi:10.1186/2047-2994-3-23 · Cited by 559
Micek, S. T., Lloyd, A. E., Ritchie, D. J., Reichley, R. M., Fraser, V. J., & Kollef, M. H. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.4.1306-1311.2005 · Cited by 526
Self-citationFailure to Recover to Baseline Pulmonary Function after Cystic Fibrosis Pulmonary Exacerbation
Sanders, D. B., Bittner, R. C. L., Rosenfeld, M., Hoffman, L. R., Redding, G. J., & Goss, C. H. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200909-1421oc · Cited by 519
A Randomized Trial of Diagnostic Techniques for Ventilator-Associated Pneumonia
(2006) · New England Journal of Medicine · doi:10.1056/nejmoa052904 · Cited by 491
Wunderink, R. G., Matsunaga, Y., Ariyasu, M., Clevenbergh, P., Echols, R., Kaye, K. S., Kollef, M., Menon, A., Pogue, J. M., Shorr, A. F., et al. (2021) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30731-3 · Cited by 475
Self-citationKumar, A., Zarychanski, R., Light, B., Parrillo, J., Maki, D., Simon, D., Laporta, D., Lapinsky, S., Ellis, P., Mirzanejad, Y., et al. (2010) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181eb3ccd · Cited by 462
Cystic Fibrosis Foundation Evidence-Based Guidelines for Management of Infants with Cystic Fibrosis
Borowitz, D., Robinson, K. A., Rosenfeld, M., Davis, S. D., Sabadosa, K. A., Spear, S. L., Michel, S. H., Parad, R. B., White, T. B., Farrell, P. M., et al. (2009) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2009.09.001 · Cited by 456
Roy‐Burman, A., Savel, R. H., Racine, S., Swanson, B. L., Revadigar, N. S., Fujimoto, J., Sawa, T., Frank, D. W., & Wiener‐Kronish, J. P. (2001) · The Journal of Infectious Diseases · doi:10.1086/320737 · Cited by 455
Torres, A., Zhong, N., Pachl, J., Timsit, J.-F., Kollef, M., Chen, Z., Song, J., Taylor, D., Laud, P. J., Stone, G. G., et al. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30747-8 · Cited by 441
Self-citationMortality in bronchiectasis: a long-term study assessing the factors influencing survival
Loebinger, M. R., Wells, A. U., Hansell, D. M., Chinyanganya, N., Devaraj, A., Meister, M., & Wilson, R. (2009) · European Respiratory Journal · doi:10.1183/09031936.00003709 · Cited by 414
Clinical Significance of Microbial Infection and Adaptation in Cystic Fibrosis
Hauser, A. R., Jain, M., Bar-Meir, M., & McColley, S. A. (2011) · Clinical Microbiology Reviews · doi:10.1128/cmr.00036-10 · Cited by 411
Hauser, A. R., Cobb, E., Bodí, M., Mariscal, D., Vallés, J., Engel, J. N., & Rello, J. (2002) · Critical Care Medicine · doi:10.1097/00003246-200203000-00005 · Cited by 399
Health Care-Associated Pneumonia and Community-Acquired Pneumonia: a Single-Center Experience
Micek, S. T., Kollef, K. E., Reichley, R. M., Roubinian, N., & Kollef, M. H. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00851-07 · Cited by 394
Self-citationInfection Prevention and Control Guideline for Cystic Fibrosis: 2013 Update
Saiman, L., Siegel, J. D., LiPuma, J. J., Brown, R. F., Bryson, E. A., Chambers, M. J., Downer, V. S., Fliege, J., Hazle, L. A., Jain, M., et al. (2014) · Infection Control & Hospital Epidemiology · doi:10.1086/676882 · Cited by 387
Zhanel, G. G., Lawrence, C. K., Adam, H., Schweizer, F., Zelenitsky, S., Zhanel, M., Lagacé-Wiens, P. R. S., Walkty, A., Denisuik, A., Golden, A., et al. (2018) · Drugs · doi:10.1007/s40265-017-0851-9 · Cited by 377
The leading causes of death after burn injury in a single pediatric burn center
Williams, F. N., Herndon, D. N., Hawkins, H. K., Lee, J. O., Cox, R. A., Kulp, G. A., Finnerty, C. C., Chinkes, D. L., & Jeschke, M. G. (2009) · Critical Care · doi:10.1186/cc8170 · Cited by 375
Pseudomonas aeruginosa Biofilms: Host Response and Clinical Implications in Lung Infections
Maurice, N. M., Bedi, B., & Sadikot, R. T. (2018) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2017-0321tr · Cited by 373
Inhaled Aztreonam Lysine for Chronic Airway Pseudomonas aeruginosa in Cystic Fibrosis
McCoy, K. S., Quittner, A. L., Oermann, C. M., Gibson, R. L., Retsch-Bogart, G. Z., & Montgomery, A. B. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200712-1804oc · Cited by 356
Kollef, M. H., Nováček, M., Kivistik, Ü., Réa-Neto, Á., Shime, N., Martin-Loeches, I., Timsit, J.-F., Wunderink, R. G., Bruno, C. J., Huntington, J. A., et al. (2019) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(19)30403-7 · Cited by 345
Self-citationNorbury, W., Herndon, D. N., Tanksley, J., Jeschke, M. G., Finnerty, C. C., & on Behalf of the Scientific Study Committee of the Surgical Infection Society (2016) · Surgical Infections · doi:10.1089/sur.2013.134 · Cited by 337
Rosenthal, V. D., Al-Abdely, H. M., El-Kholy, A. A., AlKhawaja, S. A. A., Leblebicioglu, H., Mehta, Y., Rai, V., Hung, N. V., Kanj, S. S., Salama, M. F., et al. (2016) · American Journal of Infection Control · doi:10.1016/j.ajic.2016.08.007 · Cited by 335
Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis
Langton Hewer, S. C., & Smyth, A. R. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004197.pub4 · Cited by 324
Significant Microbiological Effect of Inhaled Tobramycin in Young Children with Cystic Fibrosis
Gibson, R. L., Emerson, J., McNamara, S., Burns, J. L., Rosenfeld, M., Yunker, A., Hamblett, N., Accurso, F., Dovey, M., Hiatt, P., et al. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200208-855oc · Cited by 318
Kaye, K. S., Bhowmick, T., Metallidis, S., Bleasdale, S. C., Sagan, O. S., Stus, V., Vazquez, J., Zaitsev, V., Bidair, M., Chorvat, E., et al. (2018) · JAMA · doi:10.1001/jama.2018.0438 · Cited by 314
The Epidemiology of Burn Wound Infections: Then and Now
Weinstein, R. A., & Mayhall, C. G. (2003) · Clinical Infectious Diseases · doi:10.1086/376993 · Cited by 313
Urinary tract infections caused by Pseudomonas aeruginosa: A minireview
Mittal, R., Aggarwal, S., Sharma, S., Chhibber, S., & Harjai, K. (2009) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2009.08.003 · Cited by 312
Saiman, L. (2003) · American Journal of Infection Control · doi:10.1067/mic.2003.78 · Cited by 307
Aetiology in adult patients with bronchiectasis
Shoemark, A., Ozerovitch, L., & Wilson, R. (2007) · Respiratory Medicine · doi:10.1016/j.rmed.2006.11.008 · Cited by 303
Ratjen, F., Munck, A., Kho, P., Angyalosi, G., & for the ELITE Study Group (2010) · Thorax · doi:10.1136/thx.2009.121657 · Cited by 291
Barbier, F., Andremont, A., Wolff, M., & Bouadma, L. (2013) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0b013e32835f27be · Cited by 281
Efficacy and Safety of Inhaled Aztreonam Lysine for Airway Pseudomonas in Cystic Fibrosis
Retsch-Bogart, G. Z., Quittner, A. L., Gibson, R. L., Oermann, C. M., McCoy, K. S., Montgomery, A. B., & Cooper, P. J. (2009) · Chest · doi:10.1378/chest.08-1421 · Cited by 281
Yokoe, D. S., Mermel, L. A., Anderson, D. J., Arias, K. M., Burstin, H., Calfee, D. P., Coffin, S. E., Dubberke, E. R., Fraser, V., Gerding, D. N., et al. (2008) · Infection Control & Hospital Epidemiology · doi:10.1086/591060 · Cited by 280
Micek, S. T., Welch, E. C., Khan, J., Pervez, M., Doherty, J. A., Reichley, R. M., & Kollef, M. H. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01365-09 · Cited by 278
Self-citationGarnacho-Montero, J., Sa-Borges, M., Sole-Violan, J., Barcenilla, F., Escoresca-Ortega, A., Ochoa, M., Cayuela, A., & Rello, J. (2007) · Critical Care Medicine · doi:10.1097/01.ccm.0000275389.31974.22 · Cited by 275
Pneumonia Due to Pseudomonas aeruginosa
Fujitani, S., Sun, H.-Y., Yu, V. L., & Weingarten, J. A. (2011) · Chest · doi:10.1378/chest.10-0166 · Cited by 273
Mogayzel, P. J., Naureckas, E. T., Robinson, K. A., Brady, C., Guill, M., Lahiri, T., Lubsch, L., Matsui, J., Oermann, C. M., Ratjen, F., et al. (2014) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201404-166oc · Cited by 269
Murphy, C. N., Fowler, R., Balada-Llasat, J. M., Carroll, A., Stone, H., Akerele, O., Buchan, B., Windham, S., Hopp, A., Ronen, S., et al. (2020) · Journal of Clinical Microbiology · doi:10.1128/jcm.00128-20 · Cited by 269
Micek, S. T., Wunderink, R. G., Kollef, M. H., Chen, C., Rello, J., Chastre, J., Antonelli, M., Welte, T., Clair, B., Ostermann, H., et al. (2015) · Critical Care · doi:10.1186/s13054-015-0926-5 · Cited by 267
Self-citationUpdate of the treatment of nosocomial pneumonia in the ICU
Zaragoza, R., Vidal-Cortés, P., Aguilar, G., Borges, M., Diaz, E., Ferrer, R., Maseda, E., Nieto, M., Nuvials, F. X., Ramirez, P., et al. (2020) · Critical Care · doi:10.1186/s13054-020-03091-2 · Cited by 232
Smyth, A., Tan, K. H.-V., Hyman-Taylor, P., Mulheran, M., Lewis, S., Stableforth, D., & Knox, A. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17906-9 · Cited by 228
Titov, I., Wunderink, R. G., Roquilly, A., Rodríguez Gonzalez, D., David-Wang, A., Boucher, H. W., Kaye, K. S., Losada, M. C., Du, J., Tipping, R., et al. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa803 · Cited by 226
Changing Epidemiology of the Respiratory Bacteriology of Patients With Cystic Fibrosis
Salsgiver, E. L., Fink, A. K., Knapp, E. A., LiPuma, J. J., Olivier, K. N., Marshall, B. C., & Saiman, L. (2016) · Chest · doi:10.1378/chest.15-0676 · Cited by 224
Bucior, I., Pielage, J. F., & Engel, J. N. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002616 · Cited by 221 · cited 1×
“aeruginosa infection, the main adhesins are the single flagellum, which is necessary for motility, adhesion to cells and formation of a biofilm, and the type IV pili, which are appendages composed of pilin polymers, which allow the bacteria to move over surfaces in addition to serving relevant roles in biofilm formati…”
BackgroundPseudomonas aeruginosa: Host defence in lung diseases
WILLIAMS, B. J., DEHNBOSTEL, J., & BLACKWELL, T. S. (2010) · Respirology · doi:10.1111/j.1440-1843.2010.01819.x · Cited by 221
Treggiari, M. M., Retsch-Bogart, G., Mayer-Hamblett, N., Khan, U., Kulich, M., Kronmal, R., Williams, J., Hiatt, P., Gibson, R. L., Spencer, T., et al. (2011) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpediatrics.2011.136 · Cited by 215
Bilton, D., Canny, G., Conway, S., Dumcius, S., Hjelte, L., Proesmans, M., Tümmler, B., Vavrova, V., & De Boeck, K. (2011) · Journal of Cystic Fibrosis · doi:10.1016/s1569-1993(11)60012-x · Cited by 208
Kollef, M. H., Chastre, J., Clavel, M., Restrepo, M. I., Michiels, B., Kaniga, K., Cirillo, I., Kimko, H., & Redman, R. (2012) · Critical Care · doi:10.1186/cc11862 · Cited by 208
Self-citationKollef, M. H., Chastre, J., Fagon, J.-Y., François, B., Niederman, M. S., Rello, J., Torres, A., Vincent, J.-L., Wunderink, R. G., Go, K. W., et al. (2014) · Critical Care Medicine · doi:10.1097/ccm.0000000000000510 · Cited by 203
Self-citationLahiri, T., Hempstead, S. E., Brady, C., Cannon, C. L., Clark, K., Condren, M. E., Guill, M. F., Guillerman, R. P., Leone, C. G., Maguiness, K., et al. (2016) · Pediatrics · doi:10.1542/peds.2015-1784 · Cited by 202
Gram Negative Wound Infection in Hospitalised Adult Burn Patients-Systematic Review and Metanalysis-
Azzopardi, E. A., Azzopardi, E., Camilleri, L., Villapalos, J., Boyce, D. E., Dziewulski, P., Dickson, W. A., & Whitaker, I. S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0095042 · Cited by 183
Mechanisms and Targeted Therapies for Pseudomonas aeruginosa Lung Infection
Curran, C. S., Bolig, T., & Torabi-Parizi, P. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201705-1043so · Cited by 182
Trouillet, J. L., Vuagnat, A., Combes, A., Kassis, N., Chastre, J., & Gibert, C. (2002) · Clinical Infectious Diseases · doi:10.1086/339488 · Cited by 176
Thaden, J. T., Park, L. P., Maskarinec, S. A., Ruffin, F., Fowler, V. G., & van Duin, D. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02671-16 · Cited by 168
Type 3 secretion system of Pseudomonas aeruginosa
Horna, G., & Ruiz, J. (2021) · Microbiological Research · doi:10.1016/j.micres.2021.126719 · Cited by 167
Yokoe, D. S., Anderson, D. J., Berenholtz, S. M., Calfee, D. P., Dubberke, E. R., Ellingson, K. D., Gerding, D. N., Haas, J. P., Kaye, K. S., Klompas, M., et al. (2014) · American Journal of Infection Control · doi:10.1016/j.ajic.2014.07.002 · Cited by 164
Peña, C., Suarez, C., Ocampo-Sosa, A., Murillas, J., Almirante, B., Pomar, V., Aguilar, M., Granados, A., Calbo, E., Rodríguez-Baño, J., et al. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit223 · Cited by 164
Modulation of lung epithelial functions by Pseudomonas aeruginosa
Lau, G. W., Hassett, D. J., & Britigan, B. E. (2005) · Trends in Microbiology · doi:10.1016/j.tim.2005.05.011 · Cited by 161
Florescu, D. F., Qiu, F., McCartan, M. A., Mindru, C., Fey, P. D., & Kalil, A. C. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cir934 · Cited by 161
Parker, C. M., Kutsogiannis, J., Muscedere, J., Cook, D., Dodek, P., Day, A. G., & Heyland, D. K. (2008) · Journal of Critical Care · doi:10.1016/j.jcrc.2008.02.001 · Cited by 153
Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis
Hewer, S. C. L., & Smyth, A. R. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004197.pub5 · Cited by 142
Teerawattanapong, N., Kengkla, K., Dilokthornsakul, P., Saokaew, S., Apisarnthanarak, A., & Chaiyakunapruk, N. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix112 · Cited by 140
Inhaled aztreonam lysine vs. inhaled tobramycin in cystic fibrosis: A comparative efficacy trial
Assael, B. M., Pressler, T., Bilton, D., Fayon, M. J., Fischer, R., Chiron, R., Larosa, M., Knoop, C., McElvaney, N. G., Lewis, S. A., et al. (2012) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2012.07.006 · Cited by 139
Yokoe, D. S., Anderson, D. J., Berenholtz, S. M., Calfee, D. P., Dubberke, E. R., Ellingson, K., Gerding, D. N., Haas, J. P., Kaye, K. S., Klompas, M., et al. (2014) · Infection Control and Hospital Epidemiology · doi:10.1086/677216 · Cited by 135
Carbapenem-Resistant Pseudomonas aeruginosa at US Emerging Infections Program Sites, 2015
Walters, M. S., Grass, J. E., Bulens, S. N., Hancock, E. B., Phipps, E. C., Muleta, D. B., Mounsey, J., Kainer, M. A., Concannon, C., Dumyati, G. K., et al. (2019) · Emerging infectious diseases · doi:10.3201/eid2507.181200 · Cited by 134
Pseudomonas aeruginosa Ventilator-associated Pneumonia. Predictive Factors of Treatment Failure
Planquette, B., Timsit, J., Misset, B., Schwebel, C., Azoulay, É., Adrie, C., Vesin, A., Jamali, S., Zahar, J., Allaouchiche, B., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201210-1897oc · Cited by 129
Aarts, M.-A. W., Hancock, J., Heyland, D. K., McLeod, R. S., & Marshall, J. C. (2008) · Critical Care Medicine · doi:10.1097/01.ccm.0000297956.27474.9d · Cited by 124
Bassetti, M., Rello, J., Blasi, F., Goossens, H., Sotgiu, G., Tavoschi, L., Zasowski, E. J., Arber, M. R., McCool, R., Patterson, J. V., et al. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.106184 · Cited by 123
Persistent Infection with Pseudomonas aeruginosa in Ventilator-associated Pneumonia
Solh, A. A. E., Akinnusi, M. E., Wiener-Kronish, J. P., Lynch, S. V., Pineda, L. A., & Szarpa, K. R. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200802-239oc · Cited by 122
MucA-Mediated Coordination of Type III Secretion and Alginate Synthesis in Pseudomonas aeruginosa
Wu, W., Badrane, H., Arora, S. K., Baker, H. V., & Jin, S. (2004) · Journal of Bacteriology · doi:10.1128/jb.186.22.7575-7585.2004 · Cited by 121
Hypoxia-induced PD-L1/PD-1 crosstalk impairs T-cell function in sleep apnoea
Cubillos-Zapata, C., Avendaño-Ortiz, J., Hernandez-Jimenez, E., Toledano, V., Casas-Martin, J., Varela-Serrano, A., Torres, M., Almendros, I., Casitas, R., Fernández-Navarro, I., et al. (2017) · European Respiratory Journal · doi:10.1183/13993003.00833-2017 · Cited by 116
Vardakas, K. Z., Tansarli, G. S., Bliziotis, I. A., & Falagas, M. E. (2013) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2012.12.006 · Cited by 115
Johnson, L. E., D’Agata, E. M. C., Paterson, D. L., Clarke, L., Qureshi, Z. A., Potoski, B. A., & Peleg, A. Y. (2009) · Transplant Infectious Disease · doi:10.1111/j.1399-3062.2009.00380.x · Cited by 103
Park, S.-Y., Park, H. J., Moon, S. M., Park, K., Chong, Y. P., Kim, M., Kim, S., Lee, S., Kim, Y. S., Woo, J. H., et al. (2012) · BMC Infectious Diseases · doi:10.1186/1471-2334-12-308 · Cited by 92
Inhaled anti-pseudomonal antibiotics for long-term therapy in cystic fibrosis
Smith, S., Rowbotham, N. J., & Regan, K. H. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001021.pub3 · Cited by 92 · cited 1×
“Many patients who received inhaled aztreonam were previously treated with inhaled tobramycin [120].”
BackgroundHorna, G., Amaro, C., Palacios, A., Guerra, H., & Ruiz, J. (2019) · Scientific Reports · doi:10.1038/s41598-019-47303-4 · Cited by 92
P. aeruginosa bloodstream infections among hematological patients: an old or new question?
Cattaneo, C. M., Antoniazzi, F., Casari, S., Ravizzola, G., Gelmi, M. L., Pagani, C., D’Adda, M., Morello, E., Re, A., Borlenghi, E., et al. (2012) · Annals of Hematology · doi:10.1007/s00277-012-1424-3 · Cited by 90
Managing Pseudomonas aeruginosa respiratory infections in cystic fibrosis
Langan, K. M., Kotsimbos, T. C., & Peleg, A. Y. (2015) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000217 · Cited by 89
Micek, S. T., Welch, E. C., Khan, J., Pervez, M., Doherty, J. A., Reichley, R. M., Hoppe‐Bauer, J., Dunne, W. M., & Kollef, M. H. (2011) · Journal of Hospital Medicine · doi:10.1002/jhm.899 · Cited by 89
Self-citationBloodstream infections in neutropenic patients with haematological malignancies
Carvalho, A. S., Lagana, D., Catford, J., Shaw, D., & Bak, N. (2019) · Infection Disease & Health · doi:10.1016/j.idh.2019.08.006 · Cited by 84
Mayer-Hamblett, N., Kloster, M., Rosenfeld, M., Gibson, R. L., Retsch‐Bogart, G. Z., Emerson, J., Thompson, V., & Ramsey, B. W. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ377 · Cited by 78
Yokoe, D. S., Anderson, D. J., Berenholtz, S. M., Calfee, D. P., Dubberke, E. R., Ellingson, K., Gerding, D. N., Haas, J. P., Kaye, K. S., Klompas, M., et al. (2014) · Infection Control and Hospital Epidemiology · doi:10.1017/s0899823x00193833 · Cited by 78
Update on non-cystic fibrosis bronchiectasis
Bilton, D. (2008) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0b013e328312ed8c · Cited by 76
Zhuo, H., Yang, K. Y., Lynch, S. V., Dotson, R. H., Glidden, D. V., Singh, G., Webb, W. R., Elicker, B. M., García, Ó., Brown, R., et al. (2008) · Critical Care Medicine · doi:10.1097/ccm.0b013e318183f3f8 · Cited by 70
Mucoid Pseudomonas aeruginosa and regional inflammation in the cystic fibrosis lung
Malhotra, S., Hayes, D., & Wozniak, D. J. (2019) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2019.04.009 · Cited by 68
Tiddens, H. A. W. M., Boeck, K. D., Clancy, J., Fayon, M. J., Arets, H. G. M., Bresnik, M., Derchak, A., Lewis, S. A., & Oermann, C. M. (2014) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2014.06.003 · Cited by 66
Tofas, P., Samarkos, M., Piperaki, E., Kosmidis, C., Triantafyllopoulou, I.-D., Kotsopoulou, M., Pantazatou, A., Perlorentzou, S. P., Poulli, A., Vagia, M., et al. (2017) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2017.05.003 · Cited by 64
Novel Type III Effectors in Pseudomonas aeruginosa
Burstein, D. E., Satanower, S., Simovitch, M., Belnik, Y., Zehavi, M., Yerushalmi, G., Ben‐Aroya, S., Pupko, T., & Banin, E. (2015) · mBio · doi:10.1128/mbio.00161-15 · Cited by 60
Kaminski, A., Gupta, K. H., Goldufsky, J. W., Lee, H. W., Gupta, V., & Shafikhani, S. H. (2018) · Scientific Reports · doi:10.1038/s41598-018-32491-2 · Cited by 53
New Perspectives on Antimicrobial Agents: Ceftolozane-Tazobactam
Lizza, B. D., Betthauser, K. D., Ritchie, D. J., Micek, S. T., & Kollef, M. H. (2021) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02318-20 · Cited by 53
Self-citationMoss, J., Ehrmantraut, M. E., Banwart, B. D., Frank, D. W., & Barbieri, J. T. (2001) · Infection and Immunity · doi:10.1128/iai.69.2.1185-1188.2001 · Cited by 52
Pseudomonas aeruginosaNosocomial Pneumonia: Impact of Pneumonia Classification
Micek, S. T., Kollef, M. H., Torres, A., Chen, C., Rello, J., Chastre, J. E., Antonelli, M. M., Welte, T., Clair, B., Ostermann, H., et al. (2015) · Infection Control and Hospital Epidemiology · doi:10.1017/ice.2015.167 · Cited by 49
Self-citationCarvalhaes, C. G., Castanheira, M., Sader, H. S., Flamm, R. K., & Shortridge, D. (2018) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2018.11.021 · Cited by 48
Micek, S. T., Reichley, R. M., & Kollef, M. H. (2011) · Medicine · doi:10.1097/md.0b013e318239cf0a · Cited by 47
Self-citationVentilator-Associated Pneumonia: The Role of Emerging Diagnostic Technologies
Burnham, C. D., & Kollef, M. H. (2017) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0037-1599224 · Cited by 47
Self-citationWong, P. H. P., von Krosigk, M., Roscoe, D. L., Lau, T. T. Y., Yousefi, M., & Bowie, W. (2014) · BMC Infectious Diseases · doi:10.1186/1471-2334-14-393 · Cited by 36
Bergin, S. P., Coles, A., Calvert, S. B., Farley, J. J., Powers, J. H., Zervos, M., Sims, M. D., Kollef, M. H., Durkin, M. J., Kabchi, B. A., et al. (2020) · CHEST Journal · doi:10.1016/j.chest.2020.06.034 · Cited by 34
Self-citationEradication of Pseudomonas aeruginosa in adults with cystic fibrosis
Kenny, S. L., Shaw, T. D., Downey, D. G., Moore, J. E., Rendall, J. C., & Elborn, J. S. (2014) · BMJ Open Respiratory Research · doi:10.1136/bmjresp-2014-000021 · Cited by 28
Open follow-up study of tobramycin nebuliser solution and colistin in patients with cystic fibrosis
Adeboyeku, D., Scott, S. F., & Hodson, M. E. (2006) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2006.05.009 · Cited by 27
Elphick, H., & Scott, A. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002007.pub4 · Cited by 22
Elgohari, S., Wilson, J. A., Saei, A., Sheridan, E. A. S., & Lamagni, T. L. (2016) · Epidemiology and Infection · doi:10.1017/s0950268816003058 · Cited by 16
Limitations of Registration Trials for Nosocomial Pneumonia
Kollef, M. H., & Micek, S. T. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa926 · Cited by 2
Self-citation
Cited by
Pathogenesis of the Pseudomonas aeruginosa Biofilm: A Review
Tuon, F. F., Dantas, L. R., Suss, P. H., & Tasca Ribeiro, V. S. (2022) · Pathogens · doi:10.3390/pathogens11030300 · Cited by 422
Role of Efflux Pumps on Antimicrobial Resistance in Pseudomonas aeruginosa
Lorusso, A. B., Carrara, J. A., Barroso, C. D. N., Tuon, F. F., & Faoro, H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232415779 · Cited by 347
Elfadadny, A., Ragab, R. F., AlHarbi, M., Badshah, F., Ibáñez-Arancibia, E., Farag, A., Hendawy, A. O., De los Ríos-Escalante, P. R., Aboubakr, M., Zakai, S. A., et al. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1374466 · Cited by 340
Che, J., Shi, J., Fang, C., Zeng, X., Wu, Z., Du, Q., Tu, M., & Pan, D. (2024) · Microorganisms · doi:10.3390/microorganisms12040704 · Cited by 52
Metadata
- Authors
- Reynolds, D., & Kollef, M.
- Venue
- Drugs
- Published
- 2021-11-07
- Volume
- 81
- Issue
- 18
- Pages
- 2117-2131
- ISSN
- 0012-6667 (ISSN-L)
- 1179-1950
- OpenAlex
- W3211805452
- Cited by
- 721
- References
- 131
- FWCI
- 23.28
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.